Johnson & Johnson (JNJ)reported on Tuesday that its 3Q profit declined to $3 billion, or $1.05 per share, as compared to $3.2 billion, or $1.15 per share, in the last year same quarter.
Revised profit climbed to $1.25 per share as compared to $1.24 per share. Sales however, moved higher to $17.05 billion as compared to $16 billion.
Analysts at Wall Street predicted the company to earn $1.21 per share on sales of just below $17 billion, as per reported by a poll of FactSet.
Its competitors include Covidien plc (NYSE:COV) that surged +1.44% to $58.50 with the total traded volume of 674,949.00 shares and Pfizer Inc. (NYSE:PFE) that up +1.06% to $25.84 with the total traded volume of 14.85 million shares.
Other Healthcare stocks with bullish trend include Bristol Myers Squibb Co. (NYSE:BMY) up +0.80% to $34.20, Eli Lilly & Co. (NYSE:LLY) up +1.98% to $53.57 and Merck & Co., Inc. (NYSE:MRK) up +1.37% to $47.23, whereas with bearish trend include ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) down -18.97% to $10.65, UnitedHealth Group Inc. (NYSE:UNH) down -1.20% to $56.80 and HCA Holdings Inc (NYSE:HCA) down -2.58% to $30.98.
Johnson & Johnson (NYSE:JNJ) stock’s trade at beginning with a price of $69.30 and the current trading session climbed at a high of $69.80 other than the stock finally advanced +0.99% to $69.28.
Shares price of JNJ moved forward from its 20 days moving average with +0.80% and remote positively from 50 days moving average with +1.81%. JNJ current year earnings per share experienced a downfall of -27.11% while its current quarter performance remained +0.32%.
JNJ has a trade volume of 9.07 million shares is lesser as compared to average trading capacity of 10.43 million shares.
JNJ last month stock price volatility remained 0.83%. In its share capital JNJ has 2.76 billion outstanding shares among them 2.76 billion shares have been floated in market exchange. JNJ stock institutional ownership remained 67.00% while insider ownership included 0.02%.
The stock is ahead its 52 week low with +16.84% and lagging behind from its 52 week high price with -0.49%. Company’s beta coefficient included 0.54. Beta factors measures the amount of market risk associated with market trade.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL
